大唐集團控股(02117.HK)簽訂融銀擔保協議
大唐集團控股(02117.HK)公布,於去年12月15日,附屬廈門融銀與中國民生銀行廈門分行訂立融銀融資協議,據此,該銀行同意向廈門融銀提供最高9億元人民幣(下同)的貸款融資,到期日為2023年12月15日。於一年期的融資期限內,廈門融銀可隨時提取貸款融資。
另外,同日附屬廈門鴻孚與該銀行訂立鴻孚融資協議,據此,該銀行同意向廈門鴻孚提供最高4億元的貸款融資,到期日為2023年12月15日。於一年期的融資期限內,廈門鴻孚可隨時提取貸款融資。
當日,公司作為擔保人與該銀行簽訂融銀擔保協議,據此,公司同意以該銀行為受益人提供擔保,以擔保廈門融銀及廈門鴻孚於融銀融資協議項下的還款責任。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.